Manufacturing Novel Medicines for Inflammatory Bowel Disease
Porton Biopharma (PBL) is one of the leading British biotechnology businesses that have obtained grant funding from Innovate UK to investigate the manufacture of a new class of medicines targeting a range of clinical conditions through interaction with the human microbiome.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.